Yazdanpanah Omid, Monday Lea M, Shaik Asra N, Cantor Zachary, Chi Jie
Internal Medicine, Wayne State University School of Medicine, Detroit, USA.
Internal Medicine, John D. Dingell VA Medical Center, Detroit, USA.
Cureus. 2021 Jun 16;13(6):e15702. doi: 10.7759/cureus.15702. eCollection 2021 Jun.
Hemophagocytic lymphohistiocytosis (HLH) is a systemic inflammatory syndrome of inappropriate immune cell activation which can be rapidly fatal if not recognized and treated. Here we discuss a case of a 26-year-old male with HIV on antiretroviral therapy who presented with sepsis secondary to soft tissue infection and ultimately progressed to multi-organ dysfunction despite broad-spectrum antibiotics and an improvement in soft tissue infection. Continued fever and pancytopenia without an explanation found during additional infectious and rheumatologic testing eventually led to bone marrow biopsy and laboratory criteria consistent with HLH. Although pancytopenia is a common finding in patients with HIV, here it marked a more rapidly progressing and fatal disease, HLH. Here we highlight the difficulty in identifying and diagnosing this rare condition, including a discussion of the characteristics, outcomes, underlying etiologies, and treatment of HLH in patients with HIV.
噬血细胞性淋巴组织细胞增生症(HLH)是一种免疫细胞异常激活的全身性炎症综合征,若未得到识别和治疗,可能迅速致命。在此,我们讨论一例26岁接受抗逆转录病毒治疗的HIV男性患者,该患者因软组织感染继发败血症,尽管使用了广谱抗生素且软组织感染有所改善,但最终仍进展为多器官功能障碍。在进一步的感染性和风湿性检查中未发现明确病因的持续发热和全血细胞减少最终导致骨髓活检,其实验室标准符合HLH。虽然全血细胞减少在HIV患者中很常见,但在此病例中它标志着一种进展更快且致命的疾病——HLH。在此,我们强调识别和诊断这种罕见疾病的困难,包括对HIV患者中HLH的特征、结局、潜在病因及治疗的讨论。